News Shortcuts from other journals

Pergolide and cabergoline are associated with damage to heart valves

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7584.67 (Published 11 January 2007) Cite this as: BMJ 2007;334:67

Two European studies add to mounting evidence linking two treatments for Parkinson's disease, pergolide and cabergoline, with valvular heart disease. The first was a case control study using routine data from UK general practices. The authors found a significantly increased risk of valve …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe